Vitamins and Supplements
FDA, Amarin agree company can promote off-label use of prescription fish oil![](https://eu-images.contentstack.com/v3/assets/blt09e5e63517a16184/blt21551097cf9288e5/64d6d7d18940fbe5d8e1e9f7/amarinlogo-promo.jpg?width=700&auto=webp&quality=80&disable=upscale)
Regulatory![](https://eu-images.contentstack.com/v3/assets/blt09e5e63517a16184/blt21551097cf9288e5/64d6d7d18940fbe5d8e1e9f7/amarinlogo-promo.jpg?width=700&auto=webp&quality=80&disable=upscale)
FDA, Amarin agree company can promote off-label use of prescription fish oilFDA, Amarin agree company can promote off-label use of prescription fish oil
The FDA will not appeal a federal judge's ruling that Amarin can promote off-label uses of a prescription fish-oil pill to doctors, as long as the company's statements are truthful and not misleading.
Subscribe and receive the latest updates on trends, data, events and more.
Join 57,000+ members of the natural products community.